Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2015
>
Roche ‘Very Unlikely’ to Pursue a Midsize Acquisition Soon
Roche ‘Very Unlikely’ to Pursue a Midsize Acquisition Soon
Read also
Pharma Tariffs
Pharma Tariffs Back In Spotlight On New Trump Threat
FDA approves Lilly’s Inluriyo
FDA approves Lilly’s Inluriyo to treat advanced breast cancer
Synaffix and Qurient
Synaffix and Qurient enter licensing deal for dual-payload ADC
Biotech Stocks Facing
Biotech Stocks Facing FDA Decision In October 2025
